Accelerating access to precision oncology with decentralized MSK solutions

Name: Accelerating access to precision oncology with decentralized MSK solutions
Start: 2026-11-09
End: 2026-11-09

Starts: November 9, 2026
Ends: November 9, 2026
Format: Online
Location: VIRTUAL

About This Event

SOPHiA GENETICS is collaborating with Memorial Sloan Kettering Cancer Center (MSK) to decentralize their advanced precision oncology tools – MSK-ACCESS® for liquid biopsy and MSK-IMPACT® for comprehensive genomic profiling (CGP). By combining the clinical expertise of MSK in cancer genomics, the predictive algorithms of SOPHiA DDMTM, and the power of the global SOPHiA GENETICS network, we aim to enhance patient access to these vital tools.